Up to 50M doses of J&J vaccine sitting idle in factory: report | The Hill: Healthcare Policy

As many as 50 million doses of Johnson & Johnson's COVID-19 vaccine are sitting idle at a plant in Baltimore, waiting for the U.S. Food and Drug Administration's (FDA) approval to ship, Reuters reported.Emergent BioSolutions reportedly...